Table 5.
Adverse effects of two groups
| Project | TP group
|
GP group
|
P-value | ||
|---|---|---|---|---|---|
| III | IV | III | IV | ||
| Leukopenia, n | 15 | 0 | 28 | 5 | 0.003 |
| Thrombocytopenia, n | 18 | 3 | 38 | 7 | 0.001 |
| Nausea and vomiting, n | 31 | 5 | 32 | 2 | 0.767 |
| Liver function damage, n | 1 | 0 | 2 | 1 | 0.312 |
| Hair loss, n | 51 | 0 | 45 | 0 | 0.396 |
| Muscle and joint pain, n | 5 | 0 | 3 | 0 | 0.470 |
Notes: GP group refer to the group of patients treated with gemcitabine in combination with cisplatin. TP group refer to the group of patients treated with abraxane in combination with cisplatin.